Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
International Conference on Viral Hepatitis (ICVH) 2016
March 14 - 15, 2016; San Francisco, California
March 14 - 15, 2016San Francisco, California
ICVHShortened Hep C Combo Passes Real-World TestAn 8-week regimen of combination ledipasvir and sofosbuvir appears to clear the hepatitis C virus as well as a 12-week schedule, even in patients with very high viral loads, new research shows.
Medscape Medical News, March 18, 2016
ICVHOpioid Substitutes Do Not Impede Hep C Combo DrugsOutcomes are unaffected in patients with hepatitis C who are treated with opioid substitutes while they are taking the combination of sofosbuvir plus ledipasvir, a new analysis suggests.
Hepatitis C Treatment Viable in Primary CareThe primary care setting is fine for treating patients infected with hepatitis C, even those with significant mental illness
and previous substance abuse.